Tumor diameters, measured as an indicator of tumor growth and development, revealed that 90–120 days old K-rasLA1/+; Msh2−/− mice showed a trend toward increased tumor size (although no statistical linear trend was observed), compared with K-rasLA1/+ mice, indicative of accelerated NSCLC growth (Fig. 1C). Here, MSH2 is linked to neoplasm.